Irbesartan and Hydrochlorothiazide
- Product NDC
- 70518-2013
- 11-digit product format
- 705182013
- Labeler code
- 70518
- Product ID
- 70518-2013_c5d39391-d504-a73e-e053-2a95a90a7cb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090351
- Marketing category
- ANDA
- Marketing start
- 2019-04-12
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN; HYDROCHLOROTHIAZIDE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2013-0 | 70518201300 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2013-0) | 90 tablet | 2019-04-12 | 0000-00-00 | No | No | Current |